Work

CCR Translation for This Article from Phase II Study of Lutetium-177–Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer

Year: 2023

Type: other

Abstract: CCR Translation for This Article from Phase II Study of Lutetium-177–Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer

DOI: 10.1158/1078-0432.22452602.v1

Authors: Scott T. Tagawa, Matthew I. Milowsky, Michael Morris, Shankar Vallabhajosula, Paul Christos, Naveed H. Akhtar, Joseph Osborne, Stanley J. Goldsmith, Steve Larson, Neeta Pandit Taskar, Howard I. Scher, Neil H. Bander, David M. Nanus

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361909236

Cites:

Cited by:

Related to: 10